Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials

21 Jan 2019

Abstract excerpt

Neuroendocrine tumors (NETs) have historically been subcategorized according to histologic features and the site of anatomic origin. Here, we characterize the genomic alterations in patients enrolled in 3 phase 3 clinical trials of NET of different anatomic origins and assessed the potential correlation with clinical outcomes. Whole-exome and targeted panel sequencing was used to characterize 225 NET samples...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30667365
DOI: 10.1530/erc-18-0332

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic profiling of NETs: a comprehensive analysis of the RADIANT trialsPMID 30667365Read ↗

Whole-exome sequencing of rectal neuroendocrine tumors.Semantic proximity Read ↗

Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.Semantic proximity Read ↗

The emerging clinical relevance of genomic profiling in neuroendocrine tumours.Semantic proximity Read ↗

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.Semantic proximity Read ↗

Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasmsSemantic proximity Read ↗

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.Semantic proximity Read ↗

Genetic and epigenetic drivers of neuroendocrine tumours (NET)Semantic proximity Read ↗

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.Semantic proximity Read ↗

In-depth analysis of the genomic landscape of 86 metastatic neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targetsSemantic proximity Read ↗

Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium.Semantic proximity Read ↗

Integrated genomics and transcriptomics reveal key events in pancreatic neuroendocrine neoplasm.Semantic proximity Read ↗

GEP- NETS UPDATE: Genetics of neuroendocrine tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.